While it’s a known fact that women, on average, live longer than men, a recent report unveils a nuanced reality—women also spend more of their lives grappling with poor health. 

This week on “The Top Line,” Ayla Ellison, editor-in-chief of Fierce Healthcare and Life Sciences, explores the root causes behind this disparity and the multifacted nature of the women’s health gap. She's joined by one of the lead authors of the report, Valentina Sartori, Ph.D., and a contributor to the report, Kelle Moley, M.D.  

The report highlights that addressing the women’s health gap and investing in women’s health could inject $1 trillion into the economy annually by 2040, and Dr. Sartori explains why that number could be a significant underestimation. 

While the report provides a clear understanding of the challenges, it also sheds light on viable pathways to close the women’s health gap and create a future where women not only live longer but lead healthier lives. 

To learn more about the topics in this episode:  
Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies
White House launches new initiative aimed at investing in women's health research
Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'
CMS unveils new model to support Medicaid agencies in offering whole-person maternal health
Menopause care is still a largely untapped market. Here's why investors and startups should dive in

While it’s a known fact that women, on average, live longer than men, a <a href="https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies" data-cke-saved-href="https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies">recent report</a> unveils a nuanced reality—women also spend more of their lives grappling with poor health. 
This week on “The Top Line,” Ayla Ellison, editor-in-chief of Fierce Healthcare and Life Sciences, explores the root causes behind this disparity and the multifacted nature of the women’s health gap. She's joined by one of the lead authors of the report, Valentina Sartori, Ph.D., and a contributor to the report, Kelle Moley, M.D.  
The report highlights that addressing the women’s health gap and investing in women’s health could inject $1 trillion into the economy annually by 2040, and Dr. Sartori explains why that number could be a significant underestimation. 
While the report provides a clear understanding of the challenges, it also sheds light on viable pathways to close the women’s health gap and create a future where women not only live longer but lead healthier lives. 
To learn more about the topics in this episode:  
<ul>
<li><a href="https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies" data-cke-saved-href="https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies">Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies</a></li>
<li><a href="https://www.fiercehealthcare.com/regulatory/white-house-launches-new-initiative-aimed-investing-womens-health-research" data-cke-saved-href="https://www.fiercehealthcare.com/regulatory/white-house-launches-new-initiative-aimed-investing-womens-health-research">White House launches new initiative aimed at investing in women's health research</a></li>
<li><a href="https://www.fiercebiotech.com/biotech/1-rd-investment-female-specific-yet-organon-remains-set-discovering-holy-grail-womens" data-cke-saved-href="https://www.fiercebiotech.com/biotech/1-rd-investment-female-specific-yet-organon-remains-set-discovering-holy-grail-womens">Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'</a></li>
<li><a href="https://www.fiercehealthcare.com/regulatory/cms-unveils-new-model-support-medicaid-agencies-offering-whole-person-maternal-health" data-cke-saved-href="https://www.fiercehealthcare.com/regulatory/cms-unveils-new-model-support-medicaid-agencies-offering-whole-person-maternal-health">CMS unveils new model to support Medicaid agencies in offering whole-person maternal health</a></li>
<li><a href="https://www.fiercehealthcare.com/health-tech/menopause-care-market-remains-largely-untapped-heres-why-investors-and-startups-should" data-cke-saved-href="https://www.fiercehealthcare.com/health-tech/menopause-care-market-remains-largely-untapped-heres-why-investors-and-startups-should">Menopause care is still a largely untapped market. Here's why investors and startups should dive in</a></li>
</ul>

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Advertisement